NEW YORK, NY / ACCESSWIRE / January 16, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Net 1 UEPS Technologies, Inc. (UEPS)
Class Period: September 12, 2018 - November 8, 2018
Deadline: February 3, 2020
For more info: www.bgandg.com/ueps
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company lacked effective internal control over financial reporting; (2) the Company had misclassified its investment in Cell C Proprietary Limited; (3) the Company's financial statements for the fiscal year 2018 were overstating its income; and (4) as a result, UEPS's public statements were materially false and misleading at all relevant times.
X Financial (XYF)
Class Period: X Financial American Depositary Shares ("ADSs") pursuant and/or traceable to the Company's September 19, 2018 initial public offering (the "IPO")
Deadline: February 7, 2020
For more info: www.bgandg.com/xyf
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company's total loan facilitation amount was not growing, but rather was contracting; (2) the number of investors actively using X Financial's platform was shrinking; (3) demand from small- and medium-sized enterprises for the Company's Xiaoying Preferred Loans ("preferred loans") was plummeting; (4) the Company's preferred loans had performed so poorly that it had begun drastically scaling back its preferred loans in the first quarter of 2018, several months before the IPO, and was in the process of phasing out such loans completely; (5) demand for the Company's Xiaoying Card Loans was also plummeting; (6) the revenue and loan facilitation growth provided in the Registration Statement leading up to the IPO was achieved by relaxed credit and due diligence standards, under which the Company had underwritten tens of millions of dollars' worth of poor quality loans that suffered from a disproportionately high risk of default as compared to the Company's earlier loan vintages; (7) the Company was suffering from accelerated delinquency rates from poor quality loans that it had underwritten in the first, second, and third quarters of 2018, which had caused the Company's delinquency rate to sharply rise; (8) the Company's product mix had significantly deteriorated; (9) the Company's net revenue was on track to decline by 22% during the third quarter of 2018; and (10) as a result, defendants' statements about X Financial's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com: